Wu MJ - Search Results

1

New cytotoxic monotetrahydrofuran annonaceous acetogenins from Annona muricata.

Liaw CC, Chang FR, Lin CY, Chou CJ, Chiu HF, Wu MJ, Wu YC. Liaw CC, et al. Among authors: wu mj, wu yc. J Nat Prod. 2002 Apr;65(4):470-5. doi: 10.1021/np0105578. J Nat Prod. 2002. PMID: 11975482

2

A novel constituent from Rollinia mucosa, rollicosin, and a new approach to develop annonaceous acetogenins as potential antitumor agents.

Liaw CC, Chang FR, Wu MJ, Wu YC. Liaw CC, et al. Among authors: wu mj, wu yc. J Nat Prod. 2003 Feb;66(2):279-81. doi: 10.1021/np020236b. J Nat Prod. 2003. PMID: 12608866

3

Design, syntheses, and biological evaluations of squamostolide and its related analogs.

Lee CL, Lin CF, Lin WR, Wang KS, Chang YH, Lin SR, Wu YC, Wu MJ. Lee CL, et al. Among authors: wu mj, wu yc. Bioorg Med Chem. 2005 Oct 15;13(20):5864-72. doi: 10.1016/j.bmc.2005.05.050. Bioorg Med Chem. 2005. PMID: 15993613

4

First total synthesis of antrocamphin A and its analogs as anti-inflammatory and anti-platelet aggregation agents.

Lee CL, Huang CH, Wang HC, Chuang DW, Wu MJ, Wang SY, Hwang TL, Wu CC, Chen YL, Chang FR, Wu YC. Lee CL, et al. Among authors: wu cc, wu mj, wu yc. Org Biomol Chem. 2011 Jan 7;9(1):70-3. doi: 10.1039/c0ob00616e. Epub 2010 Nov 18. Org Biomol Chem. 2011. PMID: 21088769

5

Bullatacin, a potent antitumor Annonaceous acetogenin, induces apoptosis through a reduction of intracellular cAMP and cGMP levels in human hepatoma 2.2.15 cells.

Chiu HF, Chih TT, Hsian YM, Tseng CH, Wu MJ, Wu YC. Chiu HF, et al. Among authors: wu mj, wu yc. Biochem Pharmacol. 2003 Feb 1;65(3):319-27. doi: 10.1016/s0006-2952(02)01554-x. Biochem Pharmacol. 2003. PMID: 12527325

6

2-(6-aryl-3(Z)-hexen-1,5-diynyl)anilines as a new class of potent antitubulin agents.

Lo YH, Lin CC, Lin CF, Lin YT, Duh TH, Hong YR, Yang SH, Lin SR, Yang SC, Chang LS, Wu MJ. Lo YH, et al. Among authors: wu mj. J Med Chem. 2008 May 8;51(9):2682-8. doi: 10.1021/jm070820n. Epub 2008 Apr 3. J Med Chem. 2008. PMID: 18386884

7

Design, synthesis, biological evaluation and molecular modeling studies of 1-aryl-6-(3,4,5-trimethoxyphenyl)-3(Z)-hexen-1,5-diynes as a new class of potent antitumor agents.

Lo YH, Lin YT, Liu YP, Duh TH, Lu PJ, Wu MJ. Lo YH, et al. Among authors: wu mj. Eur J Med Chem. 2013 Apr;62:526-33. doi: 10.1016/j.ejmech.2013.01.011. Epub 2013 Jan 21. Eur J Med Chem. 2013. PMID: 23419737

8

1-(2-((Z)-6-(2-(Trifluoromethyl)phenyl)hexa-3-en-1,5-diynyl)phenyl)piperidin-2-one as a new potent apoptosis agent.

Tu YS, Duh TH, Tseng CY, Lin YT, Lo YH, Hu YL, Chen CH, Chien CM, Yang SH, Lin SR, Yang SC, Wu MJ. Tu YS, et al. Among authors: wu mj. Bioorg Med Chem. 2009 Nov 1;17(21):7412-7. doi: 10.1016/j.bmc.2009.09.042. Epub 2009 Sep 25. Bioorg Med Chem. 2009. PMID: 19818634

9

Remarkable G2/M phase arrest and apoptotic effect performed by 2-(6-aryl-3-hexen-1,5-diynyl) benzonitrile antitumor agents.

Lo YH, Lin CF, Hsieh MC, Wu MJ. Lo YH, et al. Among authors: wu mj. Bioorg Med Chem. 2004 Mar 1;12(5):1047-53. doi: 10.1016/j.bmc.2003.12.014. Bioorg Med Chem. 2004. PMID: 14980618

10

Synthesis and antitumor activity of novel enediyne-linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids.

Hu WP, Liang JJ, Kao CL, Chen YC, Chen CY, Tsai FY, Wu MJ, Chang LS, Chen YL, Wang JJ. Hu WP, et al. Among authors: wu mj. Bioorg Med Chem. 2009 Feb 1;17(3):1172-80. doi: 10.1016/j.bmc.2008.12.036. Epub 2008 Dec 24. Bioorg Med Chem. 2009. PMID: 19131253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

913 results

Search Page

Filters